{"id":2665,"date":"2021-10-18T08:36:54","date_gmt":"2021-10-18T06:36:54","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/"},"modified":"2021-10-18T08:36:55","modified_gmt":"2021-10-18T06:36:55","slug":"actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021"},"content":{"rendered":"\n<p><strong>Eficiencia de un tratamiento de duraci\u00f3n fija con Venetoclax en combinaci\u00f3n con Rituximab en pacientes con Leucemia Linfoc\u00edtica Cr\u00f3nica (LLC)<\/strong><\/p>\n\n<p><a href=\"http:\/\/www.ifth.es\/wp-content\/uploads\/2021\/07\/AFTV19N2-WEB_DEF.pdf\"><strong>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021<\/strong><\/a><\/p>\n\n<h4 class=\"wp-block-heading\"><strong>\u00cdndice<\/strong><\/h4>\n\n<h4 class=\"wp-block-heading\"><\/h4>\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-02-Edit-director-1.pdf\"><strong><span class=\"has-inline-color has-black-color\">Editorial del Director.<\/span><\/strong>\u00a0Mar\u00eda Teresa Miras Portugal<\/a><\/li><li><strong>Editorial invitado.<\/strong><ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-03A-Editorial-invitado.pdf\">Memorias del FAM, alias \u201cel Fl\u00f3rez\u201d<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-03B-Editorial-invitado-1.pdf\">Medicina basada en evidencia: el peso de los datos en la sinton\u00eda final de la terap\u00e9utica<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-03C-Editorial-invitado-1.pdf\">A discussion on the possible therapeutical use of acetylsalicylic acid on COVID-19<\/a><\/li><\/ul><\/li><li><strong>Revisiones en farmacoterapia<\/strong><ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-06B-Revisiones-en-farmacoterapia-separata-1.pdf\">Eficiencia de un tratamiento de duraci\u00f3n fija con Venetoclax en combinaci\u00f3n con Rituximab en pacientes con Leucemia Linfoc\u00edtica Cr\u00f3nica (LLC)<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-06D-Revisiones-en-farmacoterapia-1.pdf\">La radiaci\u00f3n solar y la fotoprotecci\u00f3n<\/a><\/li><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-06E-Revisiones-en-farmacoterapia-1.pdf\">Immunotherapy: the role of monoclonal antibodies in COVID-19<\/a><\/li><\/ul><\/li><li><strong>Cultura y f\u00e1rmacos<\/strong><ul><li><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFTV19N2-10-CYF-1.pdf\">Adversidades y secundarismos<\/a><\/li><\/ul><\/li><\/ul>\n<p><\/p>\n","protected":false},"featured_media":2366,"template":"","categoria_revista":[66],"class_list":["post-2665","revista","type-revista","status-publish","has-post-thumbnail","hentry","categoria_revista-2021-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Eficiencia de un tratamiento de duraci\u00f3n fija con Venetoclax en combinaci\u00f3n con Rituximab en pacientes con Leucemia Linfoc\u00edtica Cr\u00f3nica (LLC) Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 \u00cdndice Editorial del Director.\u00a0Mar\u00eda Teresa Miras Portugal Editorial invitado. Memorias del FAM, alias \u201cel Fl\u00f3rez\u201d Medicina basada en evidencia: el peso de los datos en ... Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-18T06:36:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"380\" \/>\n\t<meta property=\"og:image:height\" content=\"479\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/\",\"url\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png\",\"datePublished\":\"2021-10-18T06:36:54+00:00\",\"dateModified\":\"2021-10-18T06:36:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#primaryimage\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png\",\"width\":380,\"height\":479},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.socesfar.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\/\/www.socesfar.es\/en\/revistas\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#website\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.socesfar.es\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\/\/www.socesfar.es\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"contentUrl\":\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Socesfar\",\"https:\/\/www.linkedin.com\/company\/socesfar\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Eficiencia de un tratamiento de duraci\u00f3n fija con Venetoclax en combinaci\u00f3n con Rituximab en pacientes con Leucemia Linfoc\u00edtica Cr\u00f3nica (LLC) Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 \u00cdndice Editorial del Director.\u00a0Mar\u00eda Teresa Miras Portugal Editorial invitado. Memorias del FAM, alias \u201cel Fl\u00f3rez\u201d Medicina basada en evidencia: el peso de los datos en ... Read more","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2021-10-18T06:36:55+00:00","og_image":[{"width":380,"height":479,"url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png","datePublished":"2021-10-18T06:36:54+00:00","dateModified":"2021-10-18T06:36:55+00:00","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#primaryimage","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/10\/AFT19n2.png","width":380,"height":479},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-19-no-2-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 19, n\u00ba 2, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":1,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2665\/revisions"}],"predecessor-version":[{"id":2666,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2665\/revisions\/2666"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media\/2366"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=2665"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=2665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}